Exploring how Myriad's BRACAnalysis and Genentech's Herceptin developed different public perceptions despite similar scientific foundations.
An analysis of Italy's role in biotechnology drug innovation between 2004-2011, exploring consumption patterns, economic impacts, and future directions.
Exposing how the Medical-Industrial Complex prioritizes profits over patient care, with data visualizations and case studies revealing systemic issues in healthcare.